Skip to content
PodParley
Morgans Under the Microscope cover art

All Episodes

Morgans Under the Microscope — 96 episodes

#
Title
1

Under the microscope: Instascripts, Dr Asher Freilich CEO and Founder
2

Under the microscope: Audeara (ASX:AUA) Dr James Fielding, CEO
3

Under the microscope: Control Bionics (ASX:CBL) Rob Wong, CEO
4

Under the microscope: Healthcare update - 8 July 2021
5

Under the microscope: Volpara Health Technologies (ASX:VHT): Ralph Highnam, CEO
6

Under the microscope: Micro-X (ASX:MX1) - Peter Rowland, Managing Director
7

Under the microscope: Audeara (ASX:AUA) - Dr James Fielding, Chief Executive Officer
8

Under the microscope: Control Bionics - Rob Wong, CEO
9

Under the microscope: ResApp (ASX:RAP) – Tony Keating, CEO and MD
10

Under the microscope: Sector Update – Dr. Derek Jellinek, Senior Analyst
11

Under the microscope: Swift Media (ASX:SW1) - Pippa Leary, Chief Executive Officer
12

Under the microscope: Micro X - Peter Rowland, CEO
13

Under the microscope: Weekly Wrap Week Ending 15 January 2021
14

Under the microscrope: Neuren Pharmaceuticals - John Pilcher, Chief Executive Officer
15

Under the microscope: Antisense Therapeutics (ASX:ANP) and Neuren Pharmaceuticals (ASX:NEU)
16

Under the microscope: Healthcare Update 5 January 2020
17

Under the microscope: Medibio (ASX:MEB) - Claude Solitario, Managing Director
18

Under the microscope: Healthcare Update 26 November 2020
19

Under the microscope: Weekly Wrap Week Ending 20 November 2020
20

Under the microscope: Medlab Clinical (ASX:MDC) - Dr Sean Hall, CEO and MD
21

Under the microscope: Weekly Wrap Week Ending 13 November 2020
22

Under the microscope: Weekly Wrap Week Ending 13 November 2020
23

Under the microscope: ResApp (ASX:RAP) - Tony Keating, CEO and MD
24

Under the microscope: Covid-19 Vaccine - Dr. Derek Jellinek, Senior Analyst
25

Under the microscope: Neuren (ASX:NEU) - Jon Pilcher, Chief Executive Officer
26

Under the microscope: Volpara (ASX:VHT) - Scott Power, Senior Analyst
27

Under the microscope: Weekly Wrap Week Ending 4 September 2020
28

Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer
29

Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer
30

Under the microscope: Reporting Season – August 2020 Update
31

Under the microscope: Weekly Wrap Week Ending 31 July 2020
32

Under the microscope: Weekly Wrap Week Ending 10 July 2020
33

Under the microscope: Mach7 Technologies (ASX:M7T) - Scott Power, Senior Analyst
34

Under the microscope: Cochlear (ASX:COH) - Derek Jellinek, Senior Analyst
35

Under the microscope: Imagion Biosystems (ASX:IBX) - Robert Proulx, Chief Executive Officer
36

Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, Analyst
37

Under the microscope: ResApp Health (ASX:RAP) - Tony Keating, Managing Director & CEO
38

Under the microscope: Weekly Wrap Week Ending 5 June 2020
39

Under the microscope: Healthcare Update - Scott Power, Senior Analyst
40

Under the microscope: Neuren Pharmaceuticals (ASX:NEU) - Jon Pilcher, Chief Executive Officer
41

Under the microscope: Weekly Wrap Week Ending 29 May 2020
42

Under the microscope: Volpara Health Technologies (ASX:VHT) - Scott Power, Senior Analyst
43

Under the microscope: Resmed (ASX:RMD) - Derek Jellinek, Senior Analyst
44

Under the microscope: Weekly Wrap - Week Ending 24 April
45

Under the microscope: Company Updates - Scott Power, Senior Analyst
46

Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer
47

Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director
48

Under the microscope: Weekly Wrap Week Ending 3 April 2020
49

Under the Microscope: Weekly Wrap Week Ending 20 March 2020
50

Under the microscope: Weekly Wrap Week Ending 13 March 2020
51

Under the microscope: Oventus Medical (ASX:OVN) - Chris Hart, Chief Executive Officer
52

Under the microscope: SomnoMed (ASX:SOM) - Neil Verdal-Austin, Chief Executive Officer
53

Under the microscope: Weekly Wrap Week Ending 6 March 2020
54

Under the microscope: Weekly Wrap Week Ending 28 February 2020
55

Under The microscope: Weekly Wrap Week Ending 21 February 2020
56

Under the microscope: Reporting Season Healthcare Update - Scott Power, Senior Analyst
57

Under the microscope: Weekly Wrap Week Ending 14 February 2020
58

Under the microscope: ResApp Health (ASX:RAP) – Tony Keating, CEO and MD
59

Under the microscope: Weekly Wrap Week Ending 7 February 2020
60

Under the microscope: Weekly Wrap Week Ending 31 January 2020
61

Under the microscope: Mach7 Technologies (ASX:M7T) - Mike Lampron, Managing Director
62

Under the microscope: Weekly Wrap Week Ending 24 January 2020
63

Under the microscope: Medlab Clinical (ASX:MDC) - Sean Hall, CEO & Founder
64

Under the microscope: Weekly Wrap Week Ending 17 January 2020
65

Under the microscope: Weekly Wrap Week Ending 10 January 2020
66

Under the microscope: Sector Update - Derek Jellinek and Scott Power, Senior Analysts
67

Under the microscope: Weekly Wrap Week Ending 3 January 2020
68

Under the microscope: Radiology Convention Update Part 3 - Derek Jellinek, Senior Analyst
69

Under the microscope: Radiology Convention Update Part 2 - Derek Jellinek, Senior Analyst
70

Under the microscope: Radiology Convention Update Part 1 - Derek Jellinek, Senior Analyst
71

Under the microscope: Weekly Wrap Week Ending 20 December 2019
72

Under the microscope: Radiology Convention Update Part 4 - Derek Jellinek, Senior Analyst
73

Under the microscope: Weekly Wrap Week Ending 13 December 2019
74

Under the microscope: ResApp Health (ASX:RAP) - Tony Keating, Chief Executive Officer
75

Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer
76

Under the microscope: Weekly Wrap Week Ending 6 December 2019
77

Under the microscope: CSL R&D Day and the Imaging Sector - Scott Power, Senior Analyst
78

Under the microscope: Weekly Wrap Week Ending 29 November 2019
79

Under the microscope: NeuroScientific Biopharmaceuticals (ASX:NSB) - Matthew Liddelow, CEO & MD
80

Under the microscope: Weekly Wrap Week Ending 22 November 2019
81

Under the microscope: Weekly Wrap Week Ending 15 November 2019
82

Under the microscope: Weekly Wrap Week Ending 8 November 2019
83

Under the microscope: Volpara (ASX:VHT) - Scott Power, Senior Analyst
84

Under the microscope: Pro Medicus (ASX:PME) - Scott Power, Senior Analyst
85

Under the microscope: Imagion Biosystems (ASX:IBX) Part 1 - Mike Harsh, Non-Executive Director
86

Under the microscope: Imagion Biosystems (ASX:IBX) Part 2 - Mike Harsh, Non-Executive Director
87

Under the microscope: Weekly Wrap Week Ending 1 November 2019
88

Under the microscope: ShareRoot (ASX:SRO) - Michelle Gallagher, Chief Executive Officer
89

Under the microscope: Anatara Lifescience - Steven Lydeamore, Chief Executive Officer
90

Under the microscope: Weekly Wrap Week Ending 25 October 2019
91

Under the microscope: Volpara Health Technologies (ASX:VHT) – Dr Ralph Highnam, CEO
92

Under the microscope: Actinogen Medical (ASX:ACW) - Dr Bill Ketelbey, Chief Executive Officer
93

Under the microscope: Weekly Wrap Week Ending 18 October 2019
94

Under the microscope: Weekly Wrap Week Ending 11 October 2019
95

Under the microscope: Weekly Wrap Week Ending 4 October 2019
96

Under the microscope: Pro Medicus (ASX:PME) - Clayton Hatch, Chief Financial Officer